Study reports a prominent increase in substance use and cardiovascular disease‐related mortality in the United States between 1999 and 2019

Researchers evaluated trends in substance use and cardiovascular disease-related mortality in the United States using Centers for Disease Control and Prevention data.

First Brain-Delivered Gene Therapy Approved for AADC Deficiency

The FDA granted accelerated approval to eladocagene exuparvovec (Kebilidi) to treat children and adults with aromatic L-amino acid decarboxylase (AADC) deficiency, the agency announced Thursday.

November 15, 2024

Mindset Pharma At MAPS: Phase 2 In-Patient Trial And More

[embedded content] In this latest TDR Exclusive podcast: We’re on location at the MAPS Psychedelics Science Conference with Mindset Pharma. Mindset Co-founder and Chief Scientific

June 27, 2023

Bad Air Quality in Pregnancy Hikes Cerebral Palsy Risk in Offspring

Prenatal exposure to fine particulate matter during pregnancy was associated with a 12% higher risk of cerebral palsy for the resulting infants, a cohort study

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.